S

Savara
D

SVRA

5.75000
USD
0.10
(1.68%)
مغلق
حجم التداول
62,173
الربح لكل سهم
-1
العائد الربحي
-
P/E
-10
حجم السوق
1,178,331,469
أصول ذات صلة المقالات
المزيد

العنوان: Savara

القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).